Nanosystems for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (20 August 2024) | Viewed by 11813
Special Issue Editors
2. Guangdong Province Key Laboratory of Bioengineering Medicine, Guangzhou, China
3. Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center, Guangzhou, China
4. National Engineering Research Center of Genetic Medicine, Guangzhou, China
Interests: peptide discovery; peptide drug conjugate; drug delivery; drug release
Interests: peptide discovery; peptide delivery; nanoparticle
Interests: therapeutic proteins; liposome-assisted drug delivery; bioactive peptides and protein; growth factors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleague,
Recently, peptide and peptide drugs have attracted great attention and application due to their high specificity, low toxicity, and modification, especially in the field of tumor-targeted and tissue regeneration. More than half of all new peptide-drug candidates that enter the development pipeline fail because they are unstable with various proteases in vivo. With the rapid development of the nano-delivery system, the stability and biological activity of peptide in vivo has been improved. However, challenges remain and can eventually be overcome by diverse strategies. Hence, the development of a new generation of nanosystems for peptides with improved therapeutic efficacy holds great promise.
The aim of this Special Issue is to gather the latest studies on peptide self-assembly, peptide–drug conjugates (PDC), nano-carriers for peptide delivery, in vitro and in vivo evaluations of their stability and biological activity. Original research papers, communications, or review articles are welcome for this Special Issue.
Prof. Dr. Xiaojia Chen
Dr. Wangxiao He
Prof. Dr. Qi Xiang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peptide discovery
- peptide self-assembly
- peptide–drug conjugates
- nano-carrier for peptides
- nanoparticle
- drug delivery
- nanocarriers
- exosomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.